Gastric/Gastroesophageal Junction Cancer
5 clinical trials · Condition
◉ Watch Gastric/Gastroesophageal Junction Cancer
| Record | Firm | Date |
|---|---|---|
| KN026 in Patients With HER2 Expressing Breast Cancer and Gastric Cancer (NCT03847168) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2019-06-18 |
| KN026 in Patients With HER2 Expressing Gastric/Gastroesophageal Junction Cancer (NCT03925974) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2019-06-17 |
| A Study to Investigate Sitravatinib as Monotherapy and in Combination With Tislelizumab in Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma or Gastric/Gastroesophageal Junction Cancer (NCT03941873) | BeiGene | 2019-02-28 |
Track Gastric/Gastroesophageal Junction Cancer automatically
Every clearance here is in the API, with alerts when new ones post.